Niche transdermal Specializes in transdermal patch manufacturing including hydrogel reservoir and matrix/solvent patches, offering a focused contract manufacturing capability that can complement large pharma pipelines seeking dermal delivery options.

Tech transfer readiness Active capabilities in tech transfer, product and process scale-up, FDA clinical/exhibit batches, and commercial drug product manufacturing, enabling rapid onboarding of partner programs from development to commercialization.

SME scale advantage Small to mid-sized operation (11-50 employees) with a lower overhead footprint, presenting a potentially faster, more flexible collaboration model for niche projects and pilot manufacturing for partners.

US regional focus Operates from West Des Moines, Iowa, positioning as a domestic contract manufacturer option for US-based partners seeking proximity to regulatory bodies, faster logistics, and localized supply chain resilience.

Growth collaboration Revenue in the small-to-mid market band suggests opportunities to partner with larger players for capacity expansion, technology licensing, or co-development deals in specialized patch technologies.